12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Company News  |  Deals

Rosetta, Abbott, Monsanto deal

RSTA and ABT will use animal and human liver model systems to study the molecular basis of toxicity for a range of compounds and develop a database of the information. The companies will use...

Read the full 149 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >